In the current market session, MSCI Inc. (NYSE:MSCI) share price is at $584.80, after a 0.03% drop. Over the past month, the stock spiked by 6.91%, but over the past year, it actually decreased by 2.48%. With good short-term performance…
Amazon.com Inc.'s (NASDAQ:AMZN) stock may be struggling as it heads into 2025, but ETFs have not abandoned it. Shares of the e-commerce and cloud giant are up only 6% this year, significantly trailing the S&P 500's 18% gain. Slowing growth…
Bitmine Immersion Technologies (NYSE:BMNR) acquired 44,463 Ethereum (CRYPTO: ETH) over the past week, pushing total holdings to 4.11 million tokens worth $12.1 billion at current prices. Bitmine Now Owns 3.41% Of Ethereum Supply The crypto treasury company now holds 3.41%…
US-listed Chinese stocks traded lower on Monday, tracking declines in Hong Kong equities as thin holiday trading and weak China economic data weighed on investor sentiment. Alibaba Group Holding Limited (NYSE:BABA) stock fell after Hong Kong markets slipped into the…
Silver Foretells Please click here for a chart of silver futures (SI_F). Note the following: The chart shows the parabolic move in silver from $65 to $82.67. The chart shows a likely short term blow-off top yesterday evening. Only time…
Financial giants have made a conspicuous bearish move on PayPal Holdings. Our analysis of options history for PayPal Holdings (NASDAQ:PYPL) revealed 30 unusual trades. Delving into the details, we found 30% of traders were bullish, while 50% showed bearish tendencies.…
In the current session, the stock is trading at $23.23, after a 0.39% increase. Over the past month, Annaly Capital Management Inc. (NYSE:NLY) stock increased by 0.61%, and in the past year, by 25.41%. With performance like this, long-term shareholders…
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply on Monday. Mereo BioPharma and its partner Ultragenyx revealed results from the Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta (OI). Osteogenesis Imperfecta (OI) includes a group of…
Genmab A/S (NASDAQ:GMAB) on Monday said it will discontinue further clinical development of acasunlimab. The decision was made as part of Genmab’s strategic focus on the most value‑creating opportunities in its late‑stage portfolio and following a thorough assessment of the…
Praxis Precision Medicines Inc. (NASDAQ:PRAX) stock rose Monday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for ulixacaltamide for essential tremor (ET). Essential Tremor is the most common movement disorder, affecting roughly seven million people…